THOMAS LYNCH JR., director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital at Yale-New Haven, will leave Yale in August to become chairman and chief executive officer of the Massachusetts General Physicians Organization.
Schulam to Serve as Interim Director of Yale Cancer Center as Lynch Plans to Step Down
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Table of Contents
YOU MAY BE INTERESTED IN
Twenty-five years ago, the attack on the World Trade Center engulfed Ground Zero in a shroud of smoke, leaving Lower Manhattan covered in toxic dust for months.


For years, personalized cancer vaccines have promised to make a radical idea possible—a treatment designed not just for a particular type of cancer, but for the distinctive mutations in a patient’s tumor.


Change swept through executive offices at cancer centers in recent weeks, shifting top leadership at the University of Texas MD Anderson Cancer Center, Duke Cancer Institute, and the University of Florida.


Russian general who was accused by Ukraine’s security services of carrying out a bombing of a pediatric cancer hospital in Kyiv two years ago was shot by an unknown assassin deep inside Russia, becoming the latest in a series of Russia’s commanders to be killed or wounded in retribution for war crimes.


As Kentucky’s only National Cancer Institute-designated Comprehensive Cancer Center, the University of Kentucky Markey Cancer Center has a responsibility that extends far beyond its home in central Kentucky.
By University of Kentucky Markey Cancer Center





